ETFs Holding AVNR »    AVNR Historical Stock Prices »
AVNR News Video: Mon, Sep 15, 2014, 2:57 PM — Week Ahead Market Report: September 15, 2014

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Avanir is a pharmaceutical company focused on acquiring, developing and commercializing therapeutic products for the treatment of central nervous system disorders. The U.S. Food and Drug Administration has approved NUEDEXTA® (referred to as AVP-923 during clinical development), a combination of dextromethorphan and low-dose quinidine, for the treatment of pseudobulbar affect. Co. has commenced promotion of NUEDEXTA in the U.S. and is pursuing approval in Europe. Co. has entered into a license agreement with Concert Pharmaceuticals, Inc. (Concert) to develop and commercialize Concert's deuterium-modified dextromethorphan for the potential treatment of neurologic and psychiatric disorders. Self directed investors in Avanir Pharmaceuticals, Inc. will be interested in keeping up with all Avanir Pharmaceuticals, Inc. news they can find, both AVNR news originating from the company in the form of press releases, as well as seeing how independent media outlets are reporting news on AVNR. At RediNews, we simplify this task by presenting both AVNR news releases originating from Avanir Pharmaceuticals, Inc. itself, and AVNR news from a variety of media outlets. Visitors can browse this news online and through our AVNR RSS news feed.


AVNR News — Articles, Videos, & Press Releases

AVNR is categorized under the Healthcare sector; below are links to news for some other companies in the same sector:

PIP News
PLX News
BTX News

RediNews invites those seeking web page financial content for any internet portal, especially any vertical portal specializing in the markets where there is a web page for business, web page for markets, web page finance, etc., to integrate our free web site content, our RSS news feeds. These RSS feeds are found throughout our website wherever news and custom stock content is found, by clicking the RSS icon for any news page (which will look like this): . This dynamic financial content is ideal for sites that already feature stock data content such as historical stock price information whether in the form of a historical stock price table or a web page chart image, to supplement the other custom stock market content displayed.

AVNR News | | Copyright © 2013 - 2019, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.